PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.\', \'Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.\', \'Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.\', \'Department of Viroscience, Erasmus Medical Center, Rotterdam, 3015GD, Netherlands.\', \'Sanquin Research, Department of Experimental Immunohematology, Amsterdam, Netherlands and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1006AD Amsterdam, Netherlands.\', \'IBIS Technologies BV, 7521PR Enschede, Netherlands.\', \'Department of Virology, Biomedical Primate Research Centre, 2288GJ Rijswijk, Netherlands.\', \'Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands.\', \'Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands. m.j.vangils@amsterdamumc.nl r.w.sanders@amsterdamumc.nl g.j.debree@amsterdamumc.nl.\', \'Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105AZ Amsterdam, Netherlands. m.j.vangils@amsterdamumc.nl r.w.sanders@amsterdamumc.nl g.j.debree@amsterdamumc.nl.\', \'Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10021, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1126/science.abc5902
?:doi
?:hasPublicationType
?:journal
  • Science (New York, N.Y.)
is ?:pmid of
?:pmid
?:pmid
  • 32540902
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32540902>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32540902>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all